respiratory-syncytial-virus

Documents about respiratory-syncytial-virus

• A Study of the Membrane Binding Properties of the Matrix Protein from Human Respiratory Syncytial Virus#343956Durham e-Theses
• Safety, Tolerability and PK Study of AK0529 in Healthy Human#893480ClinicalTrials.gov
• Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic#895247ClinicalTrials.gov
• Anti-RSV Study in Chinese Patients (ASCENT)#900475ClinicalTrials.gov
• A Study of IVX-A12 in Adults Participants#992187ClinicalTrials.gov
• Respiratory Syncytial Virus Hospitalizations Among Adults in Thailand: A Nationwide Retrospective Observational Study (RSV-HAT).#168192NCBI PubMed Central
• Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)#234474ClinicalTrials.gov
• A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults#640443ClinicalTrials.gov
• BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study)#917025ClinicalTrials.gov
• A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults#864729ClinicalTrials.gov
• A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus#861588ClinicalTrials.gov
• Impact of Nirsevimab on RSV and Non-RSV Severe Respiratory Infections in Hospitalized Infants.#823908Repisalud
• Respiratory Syncytial Virus Immunization Strategies for Older Adults in Gulf Cooperation Council Countries: Expert Consensus and Recommendations.#148408NCBI PubMed Central
• Generation of apical-out nasal organoids to facilitate human respiratory syncytial virus infection and drug screening.#362242NCBI PubMed Central
• A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786#813311ClinicalTrials.gov
• A Study of TNM001 in Chinese Healthy Preterm and Term Infants#902435ClinicalTrials.gov
• Genomic Surveillance of Respiratory Syncytial Virus among Patients with Acute Respiratory Infection through Hospital-Based Influenza Surveillance Platforms in Bangladesh, August 2024-December 2025#419959bioRxiv / medRxiv
• Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers#836075ClinicalTrials.gov
• Abwassersurveillance AMELAG#14681DataCite
• The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019-2023.#123168NCBI PubMed Central
• Abwassersurveillance AMELAG#124857DataCite
• Development and Evaluation of an ARTIC-Based Amplicon Sequencing Assay for Whole-Genome Characterization of Respiratory Syncytial Virus#158276bioRxiv / medRxiv
• Integrating epidemiological and genetic data with different sampling intensities into a dynamic model of respiratory syncytial virus transmission#179567Ora Oxford University Research
• Seroepidemiology of respiratory syncytial virus infection in rural and semi-rural areas of the Littoral region of Cameroon#242874Ora Oxford University Research
• Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women#332815ClinicalTrials.gov
• Mapping the Surveillance Data Infrastructure in the U.S. for SARS-CoV-2, Influenza, and Respiratory Syncytial Virus.#479303NCBI PubMed Central
• Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers#903956ClinicalTrials.gov
• Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis#993358ClinicalTrials.gov
• Placebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly Adults#1032700ClinicalTrials.gov
• Prospective longitudinal study of respiratory syncytial virus and other respiratory viruses in children <5 years in community settings in metropolitan western Australia: the PATROL study.#162188NCBI PubMed Central
• Classifying and Differentiating Individuals with Respiratory Syncytial Virus, Influenza, and COVID-19 Cases in OpenSAFELY Between 2016 and 2024#192345bioRxiv / medRxiv
• Diagnostic Value of Oxidative Stress-Related Features Mined by WGCNA and Machine Learning in Respiratory Syncytial Virus Infection.#404348NCBI PubMed Central
• Screening of key host targets and mechanistic assessment of berberine modulation of host responses to respiratory syncytial virus.#422945NCBI PubMed Central
• Human Metapneumovirus Versus Respiratory Syncytial Virus in the Pediatric Emergency Department: Inflammatory Indices, Cycle‐Threshold Profiles and Outcomes#441574AVESIS
• Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics#867355ClinicalTrials.gov
• Epidemiology of Respiratory Viral Infections at a Combined Influenza and COVID-19 Outpatient Clinic: A Four-Month Cross-Sectional Analysis of Rapid Antigen and RT-PCR Swab Surveillance#382210HAL (France)
• Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study#142614HAL (France)
• Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above#256948ClinicalTrials.gov
• Laboratory characteristics and immune-inflammatory profiles of Mycoplasma pneumoniae and respiratory syncytial virus coinfection in children: a retrospective study.#439036NCBI PubMed Central
• Impact of Respiratory Syncytial Virus season evolution on antibody responses#470976WIReDSpace
• Label-free surface-enhanced Raman spectroscopy and machine learning for rapid classification and quantification of bovine respiratory disease complex viruses.#679697PubMed
• Development and Evaluation of an ARTIC-Based Amplicon Sequencing Assay for Whole-Genome Characterization of Respiratory Syncytial Virus#161693Unpaywall
• A Shedding Study of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF) Vaccine in Adults#279574ClinicalTrials.gov
• A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers#993249ClinicalTrials.gov
• Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients#851131ClinicalTrials.gov
• Retour d’expérience sur la première campagne d’immunisation pédiatrique par nirsévimab dans les établissements de santé français#460878HAL (France)
• Respiratory Syncytial Virus Immunization Strategies for Older Adults in Gulf Cooperation Council Countries: Expert Consensus and Recommendations#145131Springer Nature OA
• Gut Microbiome and Immune Response in Severe RSV Infection in Vietnamese Infants#882463ClinicalTrials.gov
• A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model#981283ClinicalTrials.gov
• RSV-related hospital admissions in a subset of hospitals in England and Scotland: A real-world study (2018-2023)#642286Europe PMC